Table 6.

Adverse events occurred in the 24 h after immunization in individuals vaccinated with Euvichol® during the November-December OCV campaign in a 2 km (N = 718) and 25 km (N = 1548) radius of Lake Chilwa, Malawi, December 2016.

		Population living in 2 km radius		Population living in 25 km radius
		N	%	N	%
Adverse events in the 24 h following immunization
	Yes	43	5.0 [0.1–9.8]	52	3.4 [1.5–5.3]
	Yes, one	43	6.0	51	3.3
	Yes, two	0	NA	1
	Not reported	2	0.3	0	NA
Symptoms
	Nausea	39	90.7	36	69.2
	Diarrhea	2	4.7	8	15.4
	Vomiting	2	4.7	1	1.9
	Abdominal pain	0	NA	3	5.8
	Weakness	0	NA	2	3.9
	Headache	0	NA	1	1.9
	Fever	0	NA	1	1.9
After which dose
	Dose 1	42	97.7	36	69.2
	Dose 2	1	2.3	15	28.9
	Not reported	0	NA	1	1.9
Health center attendance if adverse event
	Yes	2	4.7	1	1.9
	Not reported	0	NA	6	11.5

NA: Not applicable.